These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38548249)
81. Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins. Saint-Pol J; Eschenbrenner E; Dornier E; Boucheix C; Charrin S; Rubinstein E Biochem Soc Trans; 2017 Aug; 45(4):937-44. PubMed ID: 28687716 [TBL] [Abstract][Full Text] [Related]
82. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138 [TBL] [Abstract][Full Text] [Related]
83. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10. Hitschler L; Lang T J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353 [TBL] [Abstract][Full Text] [Related]
84. Advanced glycation end products induce endothelial hyperpermeability via β-catenin phosphorylation and subsequent up-regulation of ADAM10. Weng J; Chen Z; Li J; He Q; Chen D; Yang L; Su H; Huang J; Yu S; Huang Q; Xu Q; Guo X J Cell Mol Med; 2021 Aug; 25(16):7746-7759. PubMed ID: 34227224 [TBL] [Abstract][Full Text] [Related]
86. C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively. Xie H; Xiao Z; Huang J J Mol Neurosci; 2016 Jul; 59(3):334-42. PubMed ID: 26614345 [TBL] [Abstract][Full Text] [Related]
87. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420 [TBL] [Abstract][Full Text] [Related]
88. Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor. Scilabra SD; Pigoni M; Pravatá V; Schätzl T; Müller SA; Troeberg L; Lichtenthaler SF Sci Rep; 2018 Oct; 8(1):14697. PubMed ID: 30279425 [TBL] [Abstract][Full Text] [Related]
89. MT1-MMP and ADAM10/17 exhibit a remarkable overlap of shedding properties. Werny L; Grogro A; Bickenbach K; Bülck C; Armbrust F; Koudelka T; Pathak K; Scharfenberg F; Sammel M; Sheikhouny F; Tholey A; Linder S; Becker-Pauly C FEBS J; 2023 Jan; 290(1):93-111. PubMed ID: 35944080 [TBL] [Abstract][Full Text] [Related]
90. ADAM10 partially protects mice against influenza pneumonia by suppressing specific myeloid cell population. Okamori S; Ishii M; Asakura T; Suzuki S; Namkoong H; Kagawa S; Hegab AE; Yagi K; Kamata H; Kusumoto T; Ogawa T; Takahashi H; Yoda M; Horiuchi K; Hasegawa N; Fukunaga K Am J Physiol Lung Cell Mol Physiol; 2021 Nov; 321(5):L872-L884. PubMed ID: 34523355 [TBL] [Abstract][Full Text] [Related]
91. SRC fine-tunes ADAM10 shedding activity to promote pituitary adenoma cell progression. Huang J; Pan Y; Hu G; Sun W; Jiang L; Wang P; Ding X FEBS J; 2020 Jan; 287(1):190-204. PubMed ID: 31365784 [TBL] [Abstract][Full Text] [Related]
92. Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents. Chen C; Lv Y; Zhang BY; Zhang J; Shi Q; Wang J; Tian C; Gao C; Xiao K; Ren K; Zhou W; Dong XP Mol Neurobiol; 2014 Dec; 50(3):875-87. PubMed ID: 24771043 [TBL] [Abstract][Full Text] [Related]
93. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms. Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340 [TBL] [Abstract][Full Text] [Related]
94. 2,4-Diacetylphloroglucinol Reduces Beta-Amyloid Production and Secretion by Regulating ADAM10 and Intracellular Trafficking in Cellular and Animal Models of Alzheimer's Disease. Jang BG; Choi B; Kim S; Lee DS; Lee J; Koh YH; Jo SA; Kim JE; Kang TC; Kim MJ Cells; 2022 Aug; 11(16):. PubMed ID: 36010661 [TBL] [Abstract][Full Text] [Related]
95. The Role of Shed PrP Megra BW; Eugenin EA; Berman JW J Immunol; 2017 Jul; 199(1):224-232. PubMed ID: 28533442 [TBL] [Abstract][Full Text] [Related]
96. Membrane progesterone receptors localization in the mouse spinal cord. Labombarda F; Meffre D; Delespierre B; Krivokapic-Blondiaux S; Chastre A; Thomas P; Pang Y; Lydon JP; Gonzalez SL; De Nicola AF; Schumacher M; Guennoun R Neuroscience; 2010 Mar; 166(1):94-106. PubMed ID: 20025939 [TBL] [Abstract][Full Text] [Related]
97. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice. Tian T; Bai D; Li W; Huang GW; Liu H Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097 [TBL] [Abstract][Full Text] [Related]
98. A disintegrin and metalloprotease 10 activity sheds the ectodomain of the amyloid precursor-like protein 2 and regulates protein expression in proximal tubule cells. Cong R; Li Y; Biemesderfer D Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1366-74. PubMed ID: 21325636 [TBL] [Abstract][Full Text] [Related]
99. Broad expression of Toll-like receptors in the human central nervous system. Bsibsi M; Ravid R; Gveric D; van Noort JM J Neuropathol Exp Neurol; 2002 Nov; 61(11):1013-21. PubMed ID: 12430718 [TBL] [Abstract][Full Text] [Related]
100. Identification of SH3 domain proteins interacting with the cytoplasmic tail of the a disintegrin and metalloprotease 10 (ADAM10). Ebsen H; Lettau M; Kabelitz D; Janssen O PLoS One; 2014; 9(7):e102899. PubMed ID: 25036101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]